The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Open accessAbstract
Expression of IL-22 is induced in several human inflammatory conditions, including inflammatory bowel disease (IBD). Expression of the IL-22 receptor is restricted to innate immune cells; however, the role of IL-22 in colitis has not yet been defined. We developed what we believe to be a novel microinjection-based local gene-delivery system that is capable of targeting the inflamed intestine. Using this approach, we demonstrated a therapeutic potency for IL-22-mediated activation of the innate immune pathway in a mouse model of Th2-mediated colitis that induces disease with characteristics similar to that of IBD ulcerative colitis (UC). IL-22 gene delivery enhanced STAT3 activation specifically within colonic epithelial cells and induced both STAT3-dependent expression of mucus-associated molecules and restitution of mucus-producing goblet cells. Importantly, IL-22 gene delivery led to rapid amelioration of local intestinal inflammation. The amelioration of disease by IL-22 was mediated by enhanced mucus production. In addition, local gene delivery was used to inhibit IL-22 activity through overexpression of IL-22-binding protein. Treatment with IL-22-binding protein suppressed goblet cell restitution during the recovery phase of a dextran sulfate sodium-induced model of acute colitis. These data demonstrate what we believe to be a novel function for IL-22 in the intestine and suggest the potency of a local IL-22 gene-delivery system for treating UC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684 · cited 2×
“Since Muc family members form a static external barrier along the epithelial cell surface (33, 34), we determined whether the rapid attenuation of chronic colitis induced by supplementation of IL-22 expression was mediated by the enhanced Muc expression observed.”
BackgroundIL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359
The fundamental basis of inflammatory bowel disease
Strober, W., Fuss, I., & Mannon, P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30587 · Cited by 1,319
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
I nterleukin -10 and R elated C ytokines and R eceptors
Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., & Fisher, P. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104622 · Cited by 1,094
Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S., & Bhan, A. K. (2002) · Immunity · doi:10.1016/s1074-7613(02)00274-1 · Cited by 978
Self-citationWolk, K., Witte, E., Wallace, E., Döcke, W., Kunz, S., Asadullah, K., Volk, H., Sterry, W., & Sabat, R. (2006) · European Journal of Immunology · doi:10.1002/eji.200535503 · Cited by 922
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K., & Tonegawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)80069-q · Cited by 718
Self-citationImpaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor
Mashimo, H., Wu, D.-C., Podolsky, D. K., & Fishman, M. C. (1996) · Science · doi:10.1126/science.274.5285.262 · Cited by 701
Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology
Uhlig, H. H., McKenzie, B. S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., Robinson, N., Buonocore, S., Tlaskalova-Hogenova, H., Cua, D. J., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.017 · Cited by 682
Radaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 597
IL-23 plays a key role in Helicobacter hepaticus –induced T cell–dependent colitis
Kullberg, M. C., Jankovic, D., Feng, C. G., Hue, S., Gorelick, P. L., McKenzie, B. S., Cua, D. J., Powrie, F., Cheever, A. W., Maloy, K. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061082 · Cited by 590
Chen, Y., Thai, P., Zhao, Y.-H., Ho, Y.-S., DeSouza, M. M., & Wu, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210429200 · Cited by 577
Interleukin-17 is a negative regulator of established allergic asthma
Schnyder-Candrian, S., Togbe, D., Couillin, I., Mercier, I., Brombacher, F., Quesniaux, V., Fossiez, F., Ryffel, B., & Schnyder, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061401 · Cited by 564
Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S. T., Otte, J.-M., Diepolder, H., Marquardt, A., Jagla, W., Popp, A., et al. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00513.2005 · Cited by 549
Dumoutier, L., Louahed, J., & Renauld, J.-C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1814 · Cited by 500
Andoh, A., Zhang, Z., Inatomi, O., Fujino, S., Deguchi, Y., Araki, Y., Tsujikawa, T., Kitoh, K., Kim–Mitsuyama, S., Takayanagi, A., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.071 · Cited by 481
Self-citationTebbutt, N. C., Giraud, A. S., Inglese, M., Jenkins, B., Waring, P., Clay, F. J., Malki, S., Alderman, B. M., Grail, D., Hollande, F., et al. (2002) · Nature Medicine · doi:10.1038/nm763 · Cited by 474
Welte, T., Zhang, S. S. M., Wang, T., Zhang, Z., Hesslein, D. G. T., Yin, Z., Kano, A., Iwamoto, Y., Li, E., Craft, J. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237137100 · Cited by 381
Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans
An, G., Wei, B., Xia, B., McDaniel, J. M., Ju, T., Cummings, R. D., Braun, J., & Xia, L. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061929 · Cited by 352
Mucins in the gastrointestinal tract in health and disease
Corfield, A. (2001) · Frontiers in Bioscience · doi:10.2741/corfield · Cited by 344
The interleukin-10 family of cytokines
Fickenscher, H., Hör, S., Küpers, H., Knappe, A., Wittmann, S., & Sticht, H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02149-4 · Cited by 331
Mucins and inflammatory bowel disease
Shirazi, T. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.898.473 · Cited by 307
Cationic liposome-mediated delivery of siRNAs in adult mice
Sioud, M., & Sørensen, D. R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.057 · Cited by 286
Wolk, K., Witte, E., Hoffmann, U., Doecke, W.-D., Endesfelder, S., Asadullah, K., Sterry, W., Volk, H.-D., Wittig, B. M., & Sabat, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5973 · Cited by 270
Histochemistry of the surface mucous gel layer of the human colon.
Matsuo, K., Ota, H., Akamatsu, T., Sugiyama, A., & Katsuyama, T. (1997) · Gut · doi:10.1136/gut.40.6.782 · Cited by 270
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist
Xu, W., Presnell, S. R., Parrish-Novak, J., Kindsvogel, W., Jaspers, S., Chen, Z., Dillon, S. R., Gao, Z., Gilbert, T., Madden, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171303198 · Cited by 212
Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells
Nagalakshmi, M. L., Rascle, A., Zurawski, S., Menon, S., & de Waal Malefyt, R. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.008 · Cited by 197
Defects in mucosal immunity leading to ulcerative colitis
Targan, S. R., & Karp, L. C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00286.x · Cited by 190
Hokama, A., Mizoguchi, E., Sugimoto, K., Shimomura, Y., Tanaka, Y., Yoshida, M., Rietdijk, S. T., de Jong, Y. P., Snapper, S. B., Terhorst, C., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.009 · Cited by 171
Self-citationColitis in transgenic and knockout animals as models of human inflammatory bowel disease
Bhan, A. K., Mizoguthi, E., Smith, R. N., & Mizoguchi, A. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01316.x · Cited by 167
Self-citationMucins in the gastrointestinal tract in health and disease
Corfield, A. P. (2001) · Frontiers in bioscience · doi:10.2741/a684 · Cited by 141
Yuan, Z., Guan, Y. A., Wang, L., Wei, W., Kane, A. B., & Chin, Y. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9390-9400.2004 · Cited by 138
Mizoguchi, A., Mizoguchi, E., & Bhan, A. K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70128-9 · Cited by 134
Self-citationWirtz, S. J., Becker, C., Blumberg, R. S., Galle, P. R., & Neurath, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.411 · Cited by 133
Self-citationMucin depletion in inflammatory bowel disease.
McCormick, D. A., Horton, L. W. L., & Mee, A. S. (1990) · Journal of Clinical Pathology · doi:10.1136/jcp.43.2.143 · Cited by 131
Ho, S. B., Dvorak, L. A., Moor, R. E., Jacobson, A. C., Frey, M. R., Corredor, J., Polk, D. B., & Shekels, L. L. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.006 · Cited by 111
The Potential Role of Proteoglycans in Cationic Lipid-mediated Gene Delivery
Wiethoff, C. M., Smith, J. G., Koe, G. S., & Middaugh, C. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007940200 · Cited by 105
Jacobs, L. R., & Huber, P. W. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111662 · Cited by 104
Absence of bacterially induced RELMβ reduces injury in the dextran sodium sulfate model of colitis
McVay, L. D., Keilbaugh, S. A., Wong, T., Kierstein, S., Shin, M. E., Lehrke, M., Lefterova, M. I., Shifflett, D. E., Barnes, S. L., Cominelli, F., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28121 · Cited by 96
Colonic epithelial functional phenotype varies with type and phase of experimental colitis
Mizoguchi, E., Xavier, R. J., Reinecker, H., Uchino, H., Bhan, A. K., Podolsky, D. K., & Mizoguchi, A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00665-6 · Cited by 95
Self-citationSeril, D. N., Liao, J., Ho, K.-L. K., Yang, C. S., & Yang, G. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.993 · Cited by 91
Immune Regulation in the Intestine: A Balancing Act between Effector and Regulatory T Cell Responses
Powrie, F. M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1309.030 · Cited by 86
Logsdon, N. J., Jones, B. C., Allman, J. C., Izotova, L. S., Schwartz, B., Pestka, S., & Walter, M. R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.069 · Cited by 83
Cryan, S., & O’Driscoll, C. M. (2003) · Pharmaceutical Research · doi:10.1023/a:1023286413666 · Cited by 37
McAlindon, M. E., Galvin, A., McKaig, B. C., GRAY, T., SEWELL, H., & Mahida, Y. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00884.x · Cited by 24
Cited by
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Metadata
- Authors
- Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-02
- Volume
- 118
- Issue
- 2
- Pages
- 534-44
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2007136776
- Cited by
- 1,023
- References
- 53
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.